Frapaise Francois-Xavier 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Jan 12, 2010
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2010-01-08+30,000→ 30,000 totalExercise: $11.85Exp: 2020-01-08→ Common stock (30,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.